A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects
Clinical trial NCT01677741 · COMPLETED
Trial details
- NCT number
- NCT01677741
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-23
- Primary completion
- 2020-12-04
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.